Novartis will acquire Regulus Therapeutics for up to $1.7B, boosting its kidney drug pipeline with lead candidate farabursen.

Novartis has agreed to acquire US-based Regulus Therapeutics and its oligonucleotide, farabursen, to bolster its renal ...

Novartis has agreed to buy Regulus Therapeutics for up to $1.7 billion, giving the Swiss drugmaker access to an experimental ...

Woman baffled by painful periods had huge ovarian cyst filled with hair and teeth - Valentina Milanova was told she might ...

A research team at the Technical University of Munich (TUM) has developed a method to predict early-stage kidney damage ...

Despite the diagnosis, Valentina continued to grapple with cysts, severe pain, bloating, and heavy bleeding. Her personal ...

Polycystic kidney disease (PKD) is a genetic disorder whereby a large number of cysts develop primarily ... Repurposing ROCK2 is a viable treatment for ciliopathies, for which a limited ...

Renal cell carcinoma (RCC) is the 14th most incident cancer worldwide, and no curative therapeutic options are available for advanced and metastatic disease. Hence, new treatment alternatives are ...

Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, Jiangsu, China ...

Also read | Ovarian cysts: Warning signs, causes, types, treatment and all you want to know Ovarian cysts are usually considered harmless.(Pexels) “Most cysts do not have any symptoms and are ...